Akan Bio is a biotechnology and cellular therapy company developing next generation injectable products for the treatment of degenerative diseases and injury. Akan BIo is developing cellular therapies and proprietary manufacturing methods to produce stem cell based therapeutics using state-of-the art tissue engineering and cell-based approaches.
Looking for a particular Akan Biosciences employee's phone or email?
The Akan Biosciences annual revenue was $3 million in 2026.
Sudha Hosamane is the CFO of Akan Biosciences.
3 people are employed at Akan Biosciences.
Akan Biosciences is based in Germantown, Maryland.
The NAICS codes for Akan Biosciences are [541714, 5417, 541, 54, 54171].
The SIC codes for Akan Biosciences are [87, 873].